Brief: Magenta Therapeutics appoints Michael Vasconcelles, M.D. to the board of directors
17/08/2022 13:02
Aug 17 (Reuters) - Magenta Therapeutics Inc MGTA.O :
* MAGENTA THERAPEUTICS APPOINTS MICHAEL VASCONCELLES, M.D.
TO THE
BOARD OF DIRECTORS
Source text for Eikon: ID:nGNX271tfJ
Further company coverage: MGTA.O
Recent news on Dianthus Therapeutics
See all newsU.S. RESEARCH ROUNDUP- Adobe, Chewy, Mosaic
Brief: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
Dianthus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dianthus Therapeutics Q2 net loss widens as R&D costs rise